- Home
- SHOE vs ANGO Comparison
SHOE vs ANGO Comparison
Compare SHOE & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHOE | ANGO |
|---|---|---|
| Founded | 1978 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.3M | 420.2M |
| IPO Year | 1994 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SHOE | ANGO |
|---|---|---|
| Price | $14.54 | $12.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.75 |
| AVG Volume (30 Days) | 645.2K | ★ 729.6K |
| Earning Date | 11-24-2026 | 10-08-2026 |
| Dividend Yield | ★ 4.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,135,324,000.00 | $291,010,000.00 |
| Revenue This Year | N/A | $5.47 |
| Revenue Next Year | $2.17 | $5.10 |
| P/E Ratio | $730.50 | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $10.18 | $9.39 |
| 52 Week High | $16.29 | $16.29 |
Technical Indicators
Market Signals| Indicator | SHOE | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 47.96 |
| Support Level | $12.25 | $10.57 |
| Resistance Level | $16.00 | $12.58 |
| Average True Range (ATR) | 0.73 | 0.48 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 31.18 | 64.46 |
Price Performance
Historical ComparisonAbout SHOE Shoe Station Group Inc. Common Stock
Shoe Station Group Inc is a one-stop family footwear destination that offers an impressive selection from top brands. It is a fashion destination for footwear, southern-inspired accessories, and apparel. The group has physical stores throughout five Southern states and is available online at ShoeStation.com, shipping all across the U.S. Its offer products for Women's, Men's, and Kids.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.